Progress in the elimination of hepatitis C virus infection: A population-based cohort study in Spain
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Progress in the elimination of hepatitis C virus infection: A population-based cohort study in Spain
Authors
Keywords
Hepatitis C virus, Spain, HIV infections, Cohort studies, HIV diagnosis and management, Viral clearance, Antivirals, Antibodies
Journal
PLoS One
Volume 13, Issue 12, Pages e0208554
Publisher
Public Library of Science (PLoS)
Online
2018-12-05
DOI
10.1371/journal.pone.0208554
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Estimación de la prevalencia de infección diagnosticada y no diagnosticada por el virus de la hepatitis C en Navarra, 2014-2016
- (2018) Aitziber Aguinaga et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe
- (2018) G. V. Papatheodoridis et al. JOURNAL OF VIRAL HEPATITIS
- Population-based estimate of hepatitis C virus prevalence in Ontario, Canada
- (2018) Shelly Bolotin et al. PLoS One
- Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection in an Insured Population
- (2018) Julia L. Marcus et al. PUBLIC HEALTH REPORTS
- Micro-elimination – A path to global elimination of hepatitis C
- (2017) Jeffrey V. Lazarus et al. JOURNAL OF HEPATOLOGY
- Shift in disparities in hepatitis C treatment from interferon to DAA era: A population-based cohort study
- (2017) N. Z. Janjua et al. JOURNAL OF VIRAL HEPATITIS
- Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada
- (2017) Sahar Saeed et al. Journal of the International AIDS Society
- Evolution of acute hepatitis C virus infection in a large European city: Trends and new patterns
- (2017) César Garriga et al. PLoS One
- Disparate access to treatment regimens in chronic hepatitis C patients: data from the TRIO network
- (2016) Z. M. Younossi et al. JOURNAL OF VIRAL HEPATITIS
- Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives
- (2016) Tarik Asselah et al. LIVER INTERNATIONAL
- All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study
- (2015) David R. Nelson et al. HEPATOLOGY
- EASL Recommendations on Treatment of Hepatitis C 2015
- (2015) JOURNAL OF HEPATOLOGY
- Prevalence of hepatitis C antibodies in the population aged 16-80 years in the Community of Madrid 2008-2009
- (2015) Luis García Comas et al. JOURNAL OF MEDICAL VIROLOGY
- Hepatitis C
- (2015) Daniel P Webster et al. LANCET
- Historical epidemiology of hepatitis C virus (HCV) in selected countries
- (2014) P. Bruggmann et al. JOURNAL OF VIRAL HEPATITIS
- Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
- (2014) Jordan J. Feld et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
- (2014) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation